Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000707004 | SCV000836081 | pathogenic | Peroxisome biogenesis disorder 11A (Zellweger) | 2017-11-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PEX13 are known to be pathogenic (PMID: 10332040, 21031596). This variant has not been reported in the literature in individuals with PEX13-related disease. This variant is present in population databases (rs369851185, ExAC 0.001%). This sequence change creates a premature translational stop signal (p.Tyr155*) in the PEX13 gene. It is expected to result in an absent or disrupted protein product. |
Revvity Omics, |
RCV001784347 | SCV002021667 | likely pathogenic | not provided | 2021-04-14 | criteria provided, single submitter | clinical testing |